1,3-dipropyl-8-(4-sulfophenyl)xanthine and atenolol

1,3-dipropyl-8-(4-sulfophenyl)xanthine has been researched along with atenolol in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J1
Albino-Teixeira, A; GuimarĂ£es, S; Morato, M; Moura, D; Sousa, T1

Other Studies

2 other study(ies) available for 1,3-dipropyl-8-(4-sulfophenyl)xanthine and atenolol

ArticleYear
Chemical genetics reveals a complex functional ground state of neural stem cells.
    Nature chemical biology, 2007, Volume: 3, Issue:5

    Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells

2007
Losartan and atenolol on hypertension induced by adenosine receptor blockade.
    Autonomic & autacoid pharmacology, 2003, Volume: 23, Issue:2

    Topics: Administration, Oral; Adrenergic beta-1 Receptor Antagonists; Angiotensin II Type 2 Receptor Blockers; Animals; Atenolol; Cell Division; Disease Models, Animal; Drug Administration Schedule; Drug Therapy, Combination; Hypertension; Infusion Pumps, Implantable; Infusions, Parenteral; Losartan; Male; Mesenteric Arteries; Muscle, Smooth, Vascular; Myocardium; Purinergic P1 Receptor Antagonists; Rats; Rats, Wistar; Receptor, Angiotensin, Type 2; Receptors, Adrenergic, beta-1; Receptors, Purinergic P1; Renin; Tail; Xanthines

2003